Sugi Holdings Co.,Ltd.
Sugi Holdings Co.,Ltd.
Your view on SGIPF
Overview
What the company does, where it operates, and who runs it.
About Sugi Holdings Co.,Ltd.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Katsunori Sugiura
- Headquarters
- 62-1 Shine Yokonemachi, Obu, JP
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Katsunori Sugiura
- Headquarters
- 62-1 Shine Yokonemachi, Obu, JP
Sugi Holdings Co.,Ltd. operates drugstores in Japan. It also provides health counseling services; home-visit prescription dispensing and nursing services; medical consulting; staff agency services; disabled employment promotion; and elderly home care support services.
The company operates approximately 1,483 drugstores. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Sugi Holdings Co.,Ltd., and the rating behind it. SGIPF last traded at $16.29, 14.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Sugi Holdings Co.,Ltd.. Starting points for Sugi Holdings Co.,Ltd.: P/E 14.6, EPS $84.71, beta 0.45 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Sugi Holdings Co.,Ltd.. Sugi Holdings Co.,Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Sugi Holdings Co.,Ltd.. Trailing twelve-month EPS for Sugi Holdings Co.,Ltd. stands at $84.71. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Sugi Holdings Co.,Ltd.. Sugi Holdings Co.,Ltd. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Sugi Holdings Co.,Ltd. valued side by side against its closest peers. Sugi Holdings Co.,Ltd. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Sugi Holdings Co.,Ltd., and how their positions are changing. At a $2.95B market value, institutional positions materially move Sugi Holdings Co.,Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Sugi Holdings Co.,Ltd. executives and directors. Shares of Sugi Holdings Co.,Ltd. have traded between $16.29 and $16.29 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Sugi Holdings Co.,Ltd.. Sugi Holdings Co.,Ltd. is a $2.95B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Sugi Holdings Co.,Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Sugi Holdings Co.,Ltd.. Coverage tracks Sugi Holdings Co.,Ltd. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.